Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes

Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes

US Patent 7563774 · Granted Jul 21, 2009

Estimated economic value: $700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of thyroid beta-agonists2025
Use of thyroid beta-agonists2024
Use of thyroid beta-agonists2022
Thyromimetics for the treatment of fatty liver diseases2021
Antagonists of the glucagon receptor2020
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof2020
Thyroid hormone receptor agonist and use thereof2019
Antagonists of the glucagon receptor2019
Activators of glucokinase2019
Thyromimetics for the treatment of fatty liver diseases2018
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof2018
Factor XIa inhibitors2017